A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a ...
Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.